SCI PHARMTECH, INC. is a Taiwan-based company engaged in the research, development, manufacture and sale of active pharmaceutical ingredients and drug intermediates. The Company's active pharmaceutical ingredients include allopurinol, probucol, amobarbital, thiopental, pentobarbital sodium, sodium valproate, divalproate sodium, propafenone, thiopental and others. Its drug intermediates include diethyl dipropylmalonate, benzylmalonic acid diethyl ester, diethyl isobutylmalonate, diethyl isopropylmalonate, ethyl ethylphenylcyanoacetate and others. In addition, the Company provides specialty chemicals. The Company distributes its products within the domestic market and to overseas markets, including the rest of Asia, the Americas and Europe. On November 8, 2013, the Company announced that it has established a wholly owned subsidiary in June, 2013. On January 27, 2014, it announced that it completed the dissolution and liquidation of a wholly owned subsidiary.